P1‐061: DOUBLE‐BLIND ARGUMENT FOR A SYNERGISTIC THERAPEUTIC EFFECT OF A FIXED LOW‐DOSE COMBINATION OF ACAMPROSATE AND BACLOFEN IN ALZHEIMER'S DISEASE. (1st July 2006)